We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
80 hedge funds and large institutions have $66.1M invested in Larimar Therapeutics in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
106% more call options, than puts
Call options by funds: $377K | Put options by funds: $183K
52% more capital invested
Capital invested by funds: $43.4M → $66.1M (+$22.7M)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
0.16% more ownership
Funds ownership: 4.16% → 4.32% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 81 → 80 (-1)
22% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 32
Holders
80
Holders Change
-1
Holders Change %
-1.23%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
25
Reduced
32
Closed
7
Calls
$377K
Puts
$183K
Net Calls
+$194K
Net Calls Change
+$549K
Top Buyers
| 1 |
BlackRock
New York
|
+$5.5M |
| 2 |
AG
Artal Group
Luxembourg
|
+$2.07M |
| 3 |
JP Morgan Chase
New York
|
+$1.85M |
| 4 |
Renaissance Technologies
New York
|
+$746K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$566K |
